[Mindray Announces ADS Dividend Record Date for March 2014 Dividend SHENZHEN, China, March 7, 2014 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the] [3 EX-99.1 4]
[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 Full] [EX-99.1 2]
[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 Full] [EX-99.1 2]
[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China March 3, 2014 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]
[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China March 3, 2014 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]
[Common Stock 602675100 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 602675100 1 NAME]
[Common Stock 602675100 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 602675100 1 NAME]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,946,754 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172% Item 12: HC Cusip #Y6035S107 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172%]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,946,754 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172% Item 12: HC Cusip #Y6035S107 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172%]
[SCHEDULE 13G 01 (Amendment No. Mindray Medical International LTD (Name of Issuer) ADR 602675100 December 31, 2013 x o o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]
